Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derk J Hogenkamp

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neuropharmacology|March 23, 2011
The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibitionShahrdad Lotfipour, Monica M Arnold, Derk J Hogenkamp, et al.
Psychopharmacology|April 1, 2014
Pharmacological profile of a 17β-heteroaryl-substituted neuroactive steroidDerk J Hogenkamp, Minhtam B Tran, Ryan F Yoshimura, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2025
A conifer metabolite corrects episodic ataxia type 1 by voltage sensor-mediated ligand activation of Kv1.1Rían W Manville, Lorenzo Foglia, Ryan F Yoshimura, et al.
Epilepsy & Behavior : E&B|March 28, 2018
Role of β<sub>2/3</sub>-specific GABA-A receptor isoforms in the development of hippocampus kindling epileptogenesisDoodipala Samba Reddy, Ryan F Yoshimura, Gunasekaran Ramanathan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 23, 2022
KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicineRían W Manville, Kaitlyn E Redford, Jennifer van der Horst, et al.
Pain|September 12, 2018
Positive allosteric modulators of nonbenzodiazepine γ-aminobutyric acidA receptor subtypes for the treatment of chronic painTimothy B C Johnstone, Jennifer Y Xie, Chaoling Qu, et al.
Journal of Psychopharmacology (Oxford, England)|October 11, 2013
Limited central side effects of a β-subunit subtype-selective GABAA receptor allosteric modulatorRyan F Yoshimura, Minhtam B Tran, Derk J Hogenkamp, et al.
Journal of Medicinal Chemistry|March 5, 2004
3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockersJi Yang, Parviz Gharagozloo, Jiangchao Yao, et al.
Neuropharmacology|August 27, 2017
Allosteric modulation of nicotinic and GABA<sub>A</sub> receptor subtypes differentially modify autism-like behaviors in the BTBR mouse modelRyan F Yoshimura, Minhtam B Tran, Derk J Hogenkamp, et al.
Journal of Drug Targeting|June 7, 2006
Reversible lipidization for the oral delivery of leu-enkephalinJeffrey Wang, Derk J Hogenkamp, Minhtam Tran, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neuropharmacology|March 23, 2011
The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibitionShahrdad Lotfipour, Monica M Arnold, Derk J Hogenkamp, et al.
Psychopharmacology|April 1, 2014
Pharmacological profile of a 17β-heteroaryl-substituted neuroactive steroidDerk J Hogenkamp, Minhtam B Tran, Ryan F Yoshimura, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2025
A conifer metabolite corrects episodic ataxia type 1 by voltage sensor-mediated ligand activation of Kv1.1Rían W Manville, Lorenzo Foglia, Ryan F Yoshimura, et al.
Epilepsy & Behavior : E&B|March 28, 2018
Role of β<sub>2/3</sub>-specific GABA-A receptor isoforms in the development of hippocampus kindling epileptogenesisDoodipala Samba Reddy, Ryan F Yoshimura, Gunasekaran Ramanathan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 23, 2022
KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicineRían W Manville, Kaitlyn E Redford, Jennifer van der Horst, et al.
Pain|September 12, 2018
Positive allosteric modulators of nonbenzodiazepine γ-aminobutyric acidA receptor subtypes for the treatment of chronic painTimothy B C Johnstone, Jennifer Y Xie, Chaoling Qu, et al.
Journal of Psychopharmacology (Oxford, England)|October 11, 2013
Limited central side effects of a β-subunit subtype-selective GABAA receptor allosteric modulatorRyan F Yoshimura, Minhtam B Tran, Derk J Hogenkamp, et al.
Journal of Medicinal Chemistry|March 5, 2004
3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockersJi Yang, Parviz Gharagozloo, Jiangchao Yao, et al.
Neuropharmacology|August 27, 2017
Allosteric modulation of nicotinic and GABA<sub>A</sub> receptor subtypes differentially modify autism-like behaviors in the BTBR mouse modelRyan F Yoshimura, Minhtam B Tran, Derk J Hogenkamp, et al.
Journal of Drug Targeting|June 7, 2006
Reversible lipidization for the oral delivery of leu-enkephalinJeffrey Wang, Derk J Hogenkamp, Minhtam Tran, et al.
Pageof 2